1,186
Views
3
CrossRef citations to date
0
Altmetric
Editorial

The latest prospects of investigational drugs for head and neck cancer

&
Pages 265-268 | Received 09 Sep 2016, Accepted 03 Jan 2017, Published online: 10 Jan 2017
 

Acknowledgments

We thank Dr. Nikola Cihoric for sharing the database of http://clinicaltrial.co/.

Declaration of interest

O. Elicin and M. Ozsahin have received consultation fees from Merck Group for attending advisory board meetings. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.